http://www.laboratorytalk.com/news/can/can000.html Cancer Research UK news releases on Laboratorytalk en-gb Copyright (C)2008 Pro-Talk Ltd. All rights reserved. Tue, 14 Oct 2008 08:00:00 UT Tue, 14 Oct 2008 08:00:00 UT http://www.pro-talk.com/images/protalklogo90.gif http://www.pro-talk.com/ 90 79 Cancer Research Technology has agreed a non-exclusive licence with ArcticDx for the development of a Colo Risk test to help determine an individual's predisposition to developing colorectal cancer Mon, 04 Aug 2008 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can176.html This is the first multi-disciplinary discovery laboratory for CRT to be established outside the main London laboratory at UCL's Wolfson Institute for Biomedical Research Fri, 16 May 2008 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can175.html Specialist oncology-focused development and commercialisation company has granted an exclusive worldwide licence to Glycart Biotechnology to develop a preclinical antibody for the treatment of cancer Fri, 18 Jan 2008 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can174.html Cancer Research UK funded a record £315m of research last year, marking a near doubling in research funding since the charity was formed five years ago Mon, 17 Sep 2007 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can173.html The collaboration will generate anti-CEA scFv molecules which will be genetically fused with albumin using Novozymes proprietary Albufuse technology for future therapeutic or preventive applications. Tue, 11 Sep 2007 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can172.html The three-year research collaboration will be funded by AstraZeneca and focus on the development of cutting-edge real-time fluorescence and confocal imaging techniques Wed, 18 Jul 2007 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can171.html MCM proteins found to have potential as the basis of simple non-invasive tests for a range of cancers, including cervical, bladder, colorectal, lung, and cancer of the oesophagus Mon, 25 Jun 2007 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can170.html Cancer Research Technology and the University of Manchester announce the establishment of an alliance with AstraZeneca to develop serological pharmacodynamic (PD) biomarkers Tue, 05 Jun 2007 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can169.html The development laboratories, working on an industrial model in collaboration with the originating academics, will double in size with the number of scientists increasing from about 45 to 90 Wed, 09 May 2007 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can168.html Cancer Research Technology (CRT), the oncology-focused development and commercialisation company, has licensed rights to a panel of cancer therapeutic antibodies to Peptech Thu, 03 May 2007 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can167.html Cancer Research UK has appointed world-leading cancer researcher Professor Sir David Lane as its first chief scientist Thu, 05 Apr 2007 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can166.html Keith Blundy, 46, joined CRT - Cancer Research UK's development and commercialisation company - in 1998 and has been the company's chief operating officer since November 2003 Tue, 03 Apr 2007 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can165.html Cancer Research Technology (CRT ) and Fox Chase Cancer Center announce the initiation of an oncology-focused drug discovery collaboration Fri, 02 Mar 2007 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can164.html Waypharm has secured rights to evaluate Thioplatin a novel hypoxia-responsive platinum-based cancer therapy, from Cancer Research Technology Tue, 06 Feb 2007 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can163.html Seven of Australia's leading research organisations plus Cancer Research Technology, Bionomics, and Millipore/Chemicon, are forming the Cooperative Research Centre for Cancer Therapeutics (CRC-CT) Tue, 30 Jan 2007 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can162.html Cancer Research Technology and the University of Manchester announce a clinical pharmacology collaboration in oncology with AstraZeneca Tue, 21 Nov 2006 08:00:00 UT Cancer Research UK http://www.laboratorytalk.com/news/can/can160.html